An Efficient Heat and Peroxynitrite Generating Nanoplatform for Multimodal Imaging-guided Precision Tumor Phototherapy

Abstract

Near-infrared II (NIR-II) fluorescent nanoparticles (NPs) based on aggregation-induced emission (AIE) have attracted significant attention due to their multimodal imaging capabilities as well as the combined photothermal and photodynamic therapeutic effects in cancer therapy. Reported herein is the rational designed AIE molecule (BPT), via incorporating phenothiazine units with strong electron-donating and reactive oxygen species (ROS) generation capabilities into the classical AIE scaffold tetraphenylethylene, further coupled with a strong electron-acceptor named benzo[1,2-c:4,5-c']bis[1,2,5]thiadiazole. The BPT NPs exhibited maximum NIR-II fluorescence emission at 1083 nm, a fluorescence quantum yield of 1.53%, photothermal conversion efficiency of 63%, and photoacoustic imaging capabilities, alongside considerable type I ROS generation ability. Additionally, when a kind of nitric oxide (NO) donor named O₂-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl) piperazin-1-yl]diazen-1-ium-1,2-diolate (JSK) was incorporated, the corresponding JSK-BPT NPs could generate O₂⁻, NO, and peroxynitrite to induce phototoxicity. By applying it to the 4T1 breast tumor model, JSK-BPT NPs achieved high-quality multimodal imaging of the vasculature and tumor regions in mice. Under the multimodal imaging guidance, the 4T1 tumor could be ablated completely after a single dose of JSK-BPT NPs and under the irradiation of an 808 nm laser.

Keywords

AIE nanoparticles / gas therapy / multimodal imaging / NIR-II imaging / photothermal therapy

References

[1] Y. Liu, P. Bhattarai, Z. Dai, and X. Chen, “Photothermal Therapy and Photoacoustic Imaging via Nanotheranostics in Fighting Cancer,” Chemical Society Reviews 48 (2019): 2053.

[2] H. Sung, J. Ferlay, R. L. Siegel, et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71 (2021): 209.

[3] Y. Cai, W. Si, W. Huang, P. Chen, J. Shao, and X. Dong, “Organic Dye Based Nanoparticles for Cancer Phototheranostics,” Small 14 (2018): e1704247.

[4] C. Chen, H. Ou, R. Liu, and D. Ding, “Regulating the Photophysical Property of Organic/Polymer Optical Agents for Promoted Cancer Phototheranostics,” Advanced Materials 32 (2020): e1806331.

[5] D. Yan, T. Li, Y. Yang, et al., “A Water-Soluble AIEgen for Noninvasive Diagnosis of Kidney Fibrosis via SWIR Fluorescence and Photoacoustic Imaging,” Advanced Materials 34 (2022): e2206643.

[6] H. Xie, C. Zhang, T. Li, et al., “Fast Delivery of Multifunctional NIR-II Theranostic Nanoaggregates Enabled by the Photoinduced Thermoacoustic Process,” Advanced Science 10 (2023): e2301104.

[7] Z. Zhang, X. Fang, Z. Liu, et al., “Semiconducting Polymer Dots With Dual-Enhanced NIR-IIa Fluorescence for through-Skull Mouse-Brain Imaging,” Angewandte Chemie International Edition 59 (2020): 3691.

[8] P. Pei, Y. Chen, C. Sun, et al., “X-ray-activated Persistent Luminescence Nanomaterials for NIR-II Imaging,” Nature Nanotechnology 16 (2021): 1011.

[9] T. Pu, Y. Liu, Y. Pei, et al., “NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models,” ACS Applied Materials & Interfaces 15 (2023): 32226.

[10] J. Zhang, W. Liu, Y. Liu, et al., “A New Strategy to Elevate Absorptivity of AIEgens for Intensified NIR-II Emission and Synergized Multimodality Therapy,” Advanced Materials 35 (2023): 2306616.

[11] Y. Li, Z. Du, Y. Zhang, et al., “Boosting Theranostic Performance of AIEgens Using Nanocatalyzer for Robust Cancer Immunotherapy,” Advanced Functional Materials 34 (2024): 2315127.

[12] H. Zhang, Z. Zhao, A. T. Turley, et al., “Aggregate Science: From Structures to Properties,” Advanced Materials 32 (2020): e2001457.

[13] S. Song, Y. Zhao, M. Kang, et al., “An NIR-II Excitable AIE Small Molecule With Multimodal Phototheranostic Features for Orthotopic Breast Cancer Treatment,” Advanced Materials 36 (2024): e2309748.

[14] J. Lin, X. Zeng, Y. Xiao, et al., “Novel near-infrared II Aggregation-induced Emission Dots for in Vivo Bioimaging,” Chemical Science 10 (2019): 1219.

[15] R. Vankayala and K. C. Hwang, “Near-Infrared-Light-Activatable Nanomaterial-Mediated Phototheranostic Nanomedicines: An Emerging Paradigm for Cancer Treatment,” Advanced Materials 30 (2018): e1706320.

[16] W. Xu, D. Wang, and B. Z. Tang, “NIR-II AIEgens: A Win-Win Integration towards Bioapplications,” Angewandte Chemie International Edition 60 (2021): 7476.

[17] J. Zou, J. Zhu, Z. Yang, et al., “A Phototheranostic Strategy to Continuously Deliver Singlet Oxygen in the Dark and Hypoxic Tumor Microenvironment,” Angewandte Chemie International Edition 59 (2020): 8833.

[18] L. Yu, P. Hu, and Y. Chen, “Gas-Generating Nanoplatforms: Material Chemistry, Multifunctionality, and Gas Therapy,” Advanced Materials 30 (2018): e1801964.

[19] Z. Chen, S. Zheng, Z. Shen, et al., “Oxygen-Tolerant Photoredox Catalysis Triggers Nitric Oxide Release for Antibacterial Applications,” Angewandte Chemie International Edition 61 (2022): e202204526.

[20] X. Li, N. Kwon, T. Guo, Z. Liu, and J. Yoon, “Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy,” Angewandte Chemie International Edition 57 (2018): 11522.

[21] W. Chen, Z. Wang, M. Tian, et al., “Integration of TADF Photosensitizer as “Electron Pump” and BSA as “Electron Reservoir” for Boosting Type I Photodynamic Therapy,” Journal of the American Chemical Society 145 (2023): 8130.

[22] G. Feng, G. Q. Zhang, and D. Ding, “Design of Superior Phototheranostic Agents Guided by Jablonski Diagrams,” Chemical Society Reviews 49 (2020): 8179.

[23] Z. Wang, A. Jin, Z. Yang, and W. Huang, “Advanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications,” ACS Nano 17 (2023): 8935.

[24] Y. Wang, T. Yang, and Q. He, “Strategies for Engineering Advanced Nanomedicines for Gas Therapy of Cancer,” National Science Review 7 (2020): 1485.

[25] D. Huang, H. Huang, M. Li, et al., “A Tumor-Specific Platform of Peroxynitrite Triggering Ferroptosis of Cancer Cells,” Advanced Functional Materials 32 (2022): 2208105.

[26] H. Hu, D. Li, W. Dai, et al., “A NIR-II AIEgen-Based Supramolecular Nanodot for Peroxynitrite-Potentiated Mild-Temperature Photothermal Therapy of Hepatocellular Carcinoma,” Advanced Functional Materials 33 (2023): 2213134.

[27] J. Yang, Z. Xu, L. Yu, et al., “Organic Fluorophores With Large Stokes Shift for the Visualization of Rapid Protein and Nucleic Acid Assays,” Angewandte Chemie International Edition 63 (2024): e202318800.

[28] D. A. Phoenix and F. Harris, “Phenothiazinium-based Photosensitizers: Antibacterials of the Future?” Trends in Molecular Medicine 9 (2003): 283.

[29] E. Caffarel-Salvador, M.-C. Kearney, R. Mairs, et al., “Methylene Blue-Loaded Dissolving Microneedles: Potential Use in Photodynamic Antimicrobial Chemotherapy of Infected Wounds,” Pharmaceutics 7 (2015): 397.

[30] S. Yang, J. Zhang, Z. Zhang, et al., “More Is Better: Dual-Acceptor Engineering for Constructing Second Near-Infrared Aggregation-Induced Emission Luminogens to Boost Multimodal Phototheranostics,” Journal of the American Chemical Society 145 (2023): 22776.

[31] H. Shen, F. Sun, X. Zhu, et al., “Rational Design of NIR-II AIEgens With Ultrahigh Quantum Yields for Photo- and Chemiluminescence Imaging,” Journal of the American Chemical Society 144 (2022): 15391.

[32] J. Zhou, L. Mao, M. Wu, et al., “Extended Phenothiazines: Synthesis, Photophysical and Redox Properties, and Efficient Photocatalytic Oxidative Coupling of Amines,” Chemical Science 13 (2022): 5252.

[33] F. Chen, L. Zhao, X. Wang, et al., “Novel Boron- and Sulfur-doped Polycyclic Aromatic Hydrocarbon as Multiple Resonance Emitter for Ultrapure Blue Thermally Activated Delayed Fluorescence Polymers,” Science China Chemistry 64 (2021): 547-551.

[34] Y. Fang, J. Shang, D. Liu, W. Shi, X. Li, and H. Ma, “Design, Synthesis, and Application of a Small Molecular NIR-II Fluorophore With Maximal Emission Beyond 1200 Nm,” Journal of the American Chemical Society 142 (2020): 15271.

[35] Q. Yang, Z. Hu, S. Zhu, et al., “Donor Engineering for NIR-II Molecular Fluorophores With Enhanced Fluorescent Performance,” Journal of the American Chemical Society 140 (2018): 1715.

[36] K. Knop, R. Hoogenboom, D. Fischer, and U. S. Schubert, “Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives,” Angewandte Chemie International Edition 49 (2010): 6288.

[37] V. P. Chauhan and R. K. Jain, “Strategies for Advancing Cancer Nanomedicine,” Nature Materials 12 (2013): 958.

[38] Y.-N. Zhang, W. Poon, A. J. Tavares, I. D. McGilvray, and W. C. W. Chan, “Nanoparticle-liver Interactions: Cellular Uptake and Hepatobiliary Elimination,” Journal of Controlled Release 240 (2016): 332.

[39] I. V. Sazanovich, C. Kirmaier, E. Hindin, et al., “Structural Control of the Excited-State Dynamics of Bis(dipyrrinato)Zinc Complexes:  Self-Assembling Chromophores for Light-Harvesting Architectures,” Journal of the American Chemical Society 126 (2004): 2664.

[40] Y. Ding, Y. Tang, W. Zhu, and Y. Xie, “Fluorescent and Colorimetric Ion Probes Based on Conjugated Oligopyrroles,” Chemical Society Reviews 44 (2015): 1101.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.